Correlation Engine 2.0
Clear Search sequence regions


  • antivirals (1)
  • biogenesis (1)
  • cell (1)
  • coronavirus (1)
  • cytokines (2)
  • host (1)
  • humans (1)
  • lung (5)
  • mice (2)
  • nsp3 (3)
  • pathogenesis (1)
  • regions (1)
  • rna viral (2)
  • rna viral (4)
  • rnas (4)
  • rnase iii (1)
  • sars virus (5)
  • sequenced rnas (1)
  • Sizes of these terms reflect their relevance to your search.

    Severe acute respiratory syndrome coronavirus (SARS-CoV) causes lethal disease in humans, which is characterized by exacerbated inflammatory response and extensive lung pathology. To address the relevance of small non-coding RNAs in SARS-CoV pathology, we deep sequenced RNAs from the lungs of infected mice and discovered three 18-22 nt small viral RNAs (svRNAs). The three svRNAs were derived from the nsp3 (svRNA-nsp3.1 and -nsp3.2) and N (svRNA-N) genomic regions of SARS-CoV. Biogenesis of CoV svRNAs was RNase III, cell type, and host species independent, but it was dependent on the extent of viral replication. Antagomir-mediated inhibition of svRNA-N significantly reduced in vivo lung pathology and pro-inflammatory cytokine expression. Taken together, these data indicate that svRNAs contribute to SARS-CoV pathogenesis and highlight the potential of svRNA-N antagomirs as antivirals. Copyright © 2017 Elsevier Inc. All rights reserved.

    Citation

    Lucía Morales, Juan Carlos Oliveros, Raúl Fernandez-Delgado, Benjamin Robert tenOever, Luis Enjuanes, Isabel Sola. SARS-CoV-Encoded Small RNAs Contribute to Infection-Associated Lung Pathology. Cell host & microbe. 2017 Mar 08;21(3):344-355

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 28216251

    View Full Text